Shilpa Medicare has informed that Bio Analytical Laboratory, Shilpa Medicare, Unit 7, Nacharam, Hyderabad, India was inspected by USFDA from 26th February to 1st March 2024. The inspection was concluded with zero 483 observations and no discussion items. The Agency has concluded that this inspection has now been closed with the issuance of the Establishment Inspection Report (EIR). The facility is classified as ‘No Action Indicated' (NAI).
The above information is a part of company’s filings submitted to BSE.
